Cell Therapy News/Articles, page-5702

Not sure if posted already...

https://www.watoday.com.au/business/companies/not-for-the-faint-hearted-covid-crisis-brings-boom-time-for-biotechs-20200813-p55l93.html


Not for the faint-hearted': COVID crisis brings boom time for biotechs
By Emma Koehn
AUGUST 14, 2020

Mesoblast boss and major shareholder Silviu Itescu won’t be the only one breathing easier now that the ASX-listed biotech’s flagship treatment has managed to get the green light from the US regulator’s advisory committee.

It was a close run thing by all accounts and for Itescu and investors in Mesoblast a no vote would have seen a decade’s worth of work come to a standstill.

For his part, Itescu says he wasn’t quite as spooked as investors by signs the US Food and Drug Administration's drug advisory council was going to put Mesoblast’s treatment under severe scrutiny.

“We have been very well prepared for this meeting, we have known what the issues are and we’ve known what the answers are,” he says.

(article continues - see link above)